Informação da revista
Vol. 90. Núm. 2.
Páginas 99-101 (março - abril 2014)
Vol. 90. Núm. 2.
Páginas 99-101 (março - abril 2014)
EDITORIAL
Open Access
Vitamin D as a modifiable risk factor in critical illness: questions and answers provided by observational studies
Vitamina D como um fator de risco modificável em doenças graves: perguntas e respostas de estudos observacionais
Visitas
4952
J. Dayre McNally
Departamento de Pediatria, Faculdade de Medicina, University of Ottawa; Children's Hospital of Eastern Ontario, Ottawa, Canadá
Conteúdo relacionado
J Pediatr (Rio J). 2014;90:135-4210.1016/j.jpedp.2013.08.010
Corsino Rey, David Sánchez-Arango, Jesús López-Herce, Pablo Martínez-Camblor, Irene García-Hernández, Belén Prieto, Zamir Pallavicini
Este item recebeu
Informação do artigo
O texto completo está disponível em PDF
Referências
[1]
P. Lee, J.A. Eisman, J.R. Center.
Vitamin D deficiency in critically ill patients.
N Engl J Med., 360 (2009), pp. 1912-1914
[2]
K. Amrein, H. Sourij, G. Wagner, A. Holl, T.R. Pieber, K.H. Smolle, et al.
Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study.
Crit Care., 15 (2011), pp. R104
[3]
J.M. Mata-Granados, J. Vargas-Vasserot, C. Ferreiro-Vera, M.D. Luque de Castro, R.G. Pavón, J.M. Quesada Gómez.
Evaluation of vitamin D endocrine system (VDES) status and response to treatment of patients in intensive care units (ICUs) using an on-line SPE-LC-MS/MS method.
J Steroid Biochem Mol Biol., 121 (2010), pp. 452-455
[4]
K. Amrein, C. Schnedl, A. Berghold, T.R. Pieber, H. Dobnig.
Correction of vitamin D deficiency in critically ill patients - VITdAL@ICU study protocol of a double-blind, placebo-controlled randomized clinical trial.
BMC Endocr Disord., 12 (2012), pp. 27
[5]
C. Rey, D. Sánchez-Arango, J. López-Herce, P. Martínez-Camblor, I. García-Hernández, B. Prieto, et al.
Vitamin D deficiency at pediatric intensive care admission.
J Pediatr (Rio J)., 90 (2014), pp. 135-142
[6]
J.D. McNally, K. Menon.
Vitamin D deficiency in surgical congenital heart disease: prevalence and relevance.
Transl Pediatr., 2 (2013), pp. 99-111
[7]
J.D. McNally, K. Menon, P. Chakraborty, L. Fisher, K.A. Williams, O.Y. Al- Dirbashi, et al.
The association of vitamin D status with pediatric critical illness.
Pediatrics., 130 (2012), pp. 429-436
[8]
K. Madden, H.A. Feldman, E.M. Smith, C.M. Gordon, S.M. Keisling, R.M. Sullivan, et al.
Vitamin D deficiency in critically ill children.
Pediatrics., 130 (2012), pp. 421-428
[9]
C. Rippel, M. South, W.W. Butt, L.S. Shekerdemian.
Vitamin D status in critically ill children.
Intensive Care Med., 38 (2012), pp. 2055-2062
[10]
E.M. Graham, S.N. Taylor, S.C. Zyblewski, B. Wolf, S.M. Bradley, B.W. Hollis, et al.
Vitamin D status in neonates undergoing cardiac operations: relationship to cardiopulmonary bypass and association with outcomes.
J Pediatr., 162 (2013), pp. 823-826
[11]
J.D. McNally, K. Menon, P. Chakraborty, L. Fisher, K.A. Williams, O.Y. Al- Dirbashi, et al.
Impact of anesthesia and surgery for congenital heart disease on the vitamin D status of infants and children: a prospective longitudinal study.
Anesthesiology., 119 (2013), pp. 71-80
[12]
S. Gallo, K. Comeau, C. Vanstone, S. Agellon, A. Sharma, G. Jones, et al.
Effect of different dosages of oral vitamin D supplementation on vitamin D status in healthy, breastfed infants: a randomized trial.
JAMA., 309 (2013), pp. 1785-1792
[13]
E. Holmlund-Suila, H. Viljakainen, T. Hytinantti, C. Lamberg-Allardt, S. Andersson, O. Mäkitie.
High-dose vitamin d intervention in infants – effects on vitamin D status, calcium homeostasis, and bone strength.
J Clin Endocrinol Metab., 97 (2012), pp. 4139-4147
[14]
M. Goncerzewicz, J. Ryzko, R. Lorenc, K. Kozlowski, J. Socha.
Vitamin D metabolism in children with malabsorption syndrome.
Klin Padiatr., 197 (1985), pp. 30-34
[15]
N. Collins, J. Maher, M. Cole, M. Baker, N. Callaghan.
A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia.
Q J Med., 78 (1991), pp. 113-122
[16]
T. Emel, D.A. Doğan, G. Erdem, O. Faruk.
Therapy strategies in vitamin D deficiency with or without rickets: efficiency of low-dose stoss therapy.
J Pediatr Endocrinol Metab., 25 (2012), pp. 107-110
[17]
A.T. Soliman, M. Eldabbagh, A. Elawwa, R. Ashour, W. Saleem.
The effect of vitamin D therapy on hematological indices in children with vitamin D deficiency.
J Trop Pediatr., 58 (2012), pp. 523-524
[18]
C. Munns, M.R. Zacharin, C.P. Rodda, J.A. Batch, R. Morley, N.E. Cranswick, et al.
Prevention and treatment of infant and childhood vitamin D deficiency in Australia and New Zealand: a consensus statement.
Med J Aust., 185 (2006), pp. 268-272
[19]
T. Markestad, V. Hesse, M. Siebenhuner, G. Jahreis, L. Aksnes, W. Plenert, et al.
Intermittent high-dose vitamin D prophylaxis during infancy: effect on vitamin D metabolites, calcium, and phosphorus.
Am J Clin Nutr., 46 (1987), pp. 652-658
[20]
R. Joshi.
Hypercalcemia due to hypervitaminosis D: report of seven patients.
J Trop Pediatr., 55 (2009), pp. 396-398
Copyright © 2013. Brasileira de Pediatria